Home
>
Assessments
>
Continuous Glucose Monitoring in Patients with Diabetes Mellitus on Insulin
Continuous Glucose Monitoring in Patients with Diabetes Mellitus on Insulin
| Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered. |
| Review Date: |
March 11, 2009 |
| Recommendation: |
It is recommended that continuous glucose monitoring devices meet CTAF criteria 1-5 for safety, effectiveness and improvement in health outcomes for the management of Type 1 diabetes mellitus in non-pregnant adults requiring multiple (≥3) daily insulin injections and frequent (≥3) self-monitoring blood glucose checks.
It is further recommended that continuous glucose monitoring devices do not meet CTAF criteria 3-5 for safety, effectiveness and improvement in health outcomes for the management of Type 1 diabetes mellitus in children, adolescents and pregnant women. |
| Decision: |
Partially Meets CTAF Criteria |
| Full Assessment: |
Download (PDF) |
| History: |
October 8, 2003: Continuous Glucose Monitoring Devices in Diabetes Mellitus (including the Continuous Glucose Monitoring System and GlucoWatch Biographer) |
|
|
© 2012 California Technology Assessment Forum. All rights reserved.
